Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Nanoparticle delivery of suicide DNA for epithelial ovarian cancer therapy.

Sawicki JA, Anderson DG, Langer R.

Adv Exp Med Biol. 2008;622:209-19. doi: 10.1007/978-0-387-68969-2_17. Review.

PMID:
18546630
2.

Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice.

Huang YH, Zugates GT, Peng W, Holtz D, Dunton C, Green JJ, Hossain N, Chernick MR, Padera RF Jr, Langer R, Anderson DG, Sawicki JA.

Cancer Res. 2009 Aug 1;69(15):6184-91. doi: 10.1158/0008-5472.CAN-09-0061.

3.

Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax.

Roby KF, Niu F, Rajewski RA, Decedue C, Subramaniam B, Terranova PF.

Adv Exp Med Biol. 2008;622:169-81. Review. No abstract available.

PMID:
18546627
4.

The enhanced antitumor effects of biodegradable cationic heparin-polyethyleneimine nanogels delivering HSulf-1 gene combined with cisplatin on ovarian cancer.

Liu P, Gou M, Yi T, Qi X, Xie C, Zhou S, Deng H, Wei Y, Zhao X.

Int J Oncol. 2012 Oct;41(4):1504-12. doi: 10.3892/ijo.2012.1558. Epub 2012 Jul 18.

PMID:
22825572
5.

Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

Yang F, Gou M, Deng H, Yi T, Zhong Q, Wei Y, Zhao X.

Oncol Rep. 2012 Aug;28(2):668-76. doi: 10.3892/or.2012.1853. Epub 2012 Jun 6.

PMID:
22684947
7.

Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.

Devalapally H, Duan Z, Seiden MV, Amiji MM.

Clin Cancer Res. 2008 May 15;14(10):3193-203. doi: 10.1158/1078-0432.CCR-07-4973.

8.

Targeting ovarian cancer-initiating cells.

Murphy SK.

Anticancer Agents Med Chem. 2010 Feb;10(2):157-63. Review.

PMID:
20184540
9.

Targeting Aurora kinases in ovarian cancer.

Fu S, Hu W, Kavanagh JJ, Bast RC Jr.

Expert Opin Ther Targets. 2006 Feb;10(1):77-85. Review.

PMID:
16441230
10.

Drug delivery approaches for ovarian cancer therapy.

Malek A.

Methods Mol Biol. 2013;1049:437-42. doi: 10.1007/978-1-62703-547-7_33.

PMID:
23913236
11.

Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy.

Mastorakos P, da Silva AL, Chisholm J, Song E, Choi WK, Boyle MP, Morales MM, Hanes J, Suk JS.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8720-5. doi: 10.1073/pnas.1502281112. Epub 2015 Jun 29.

12.

Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: many questions, much promise....

Gaillard S, Armstrong D.

Oncology (Williston Park). 2011 Feb;25(2):176, 178, 180. No abstract available.

PMID:
21456389
13.

Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.

Kong B, Wang W, Liu C, Song L, Ma D, Qu X, Jiang J, Yang X, Zhang Y, Wang B, Wei MQ, Yang Q.

In Vivo. 2003 Mar-Apr;17(2):153-6.

PMID:
12792977
14.

Advances in epithelial ovarian cancer therapy.

Kroep JR.

Curr Pharm Des. 2012;18(25):3735-40.

PMID:
22591426
15.
16.

Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors.

Cao P, Mooney R, Tirughana R, Abidi W, Aramburo S, Flores L, Gilchrist M, Nwokafor U, Haber T, Tiet P, Annala AJ, Han E, Dellinger T, Aboody KS, Berlin JM.

Bioconjug Chem. 2017 Jun 21;28(6):1767-1776. doi: 10.1021/acs.bioconjchem.7b00237. Epub 2017 May 18.

PMID:
28453256
17.

An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.

Markman M.

Cancer J. 2009 Mar-Apr;15(2):105-9. doi: 10.1097/PPO.0b013e31819e31f2. Review.

PMID:
19390303
18.

A combinatorial polymer library approach yields insight into nonviral gene delivery.

Green JJ, Langer R, Anderson DG.

Acc Chem Res. 2008 Jun;41(6):749-59. doi: 10.1021/ar7002336.

19.

Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.

Pridgen EM, Langer R, Farokhzad OC.

Nanomedicine (Lond). 2007 Oct;2(5):669-80. Review.

PMID:
17976029
20.

Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.

Lu H, Li B, Kang Y, Jiang W, Huang Q, Chen Q, Li L, Xu C.

Cancer Chemother Pharmacol. 2007 Feb;59(2):175-81. Epub 2006 May 23.

PMID:
16718469

Supplemental Content

Support Center